Panorama non-invasive prenatal test

Highly accurate, comprehensive results you can trust

Panorama non-invasive prenatal test




Vistara single-gene non-invasive prenatal test




Anora miscarriage




Horizon advanced carrier screening



What is Panorama?

Panorama is a noninvasive prenatal screening test (NIPT) that reveals your baby’s risk for genetic disorders as early as nine weeks. Panorama analyzes baby’s (placental) DNA through a simple blood draw from the mother’s arm.

Screening options >>


The only prenatal blood test that can tell you whether your twins are identical or fraternal, as early as nine weeks

PANORAMA
FOR TWINS



Learn more

Identifies the sex of
each of the twins



Learn more

Information related
to zigziness



Learn more

Identify the most
genetic abnormalities


WHY CHOOSE PANORAMA



Product features


• Panorama can be performed as early as nine weeks into pregnancy.

• Panorama is performed with a simple blood draw from the mother’s arm, posing no risk to the fetus.

• Panorama is performed with a simple blood draw from the mother’s arm, posing no risk to the fetus.

• Panorama offers complimentary pre- and post-test information sessions with board-certified genetic counselors.

• More than 500,000 women in more than 60 countries have chosen Panorama.

Download Brochure >>


Clinical advantage


• Panorama detects conditions that other tests can’t, including molar pregnancy, triploidy and vanishing twin.

• Panorama screens for Down syndrome with an accuracy rate greater than 99%.

• Panorama is the only test that differentiates between maternal and fetal DNA, which helps avoid false positives.

• Among commercially available NIPTs, Panorama has the highest published accuracy in determining the baby’s gender.

• Panorama has the highest sensitivity for 22q11.2 deletion syndrome, a common and potential severe microdeletion that impacts women equally regardless of age.

Learn more >>



Conditions screened

Panorama screens for common genetic conditions that are caused by extra or missing chromosomes in the baby’s DNA. Panorama is the only NIPT on the market that tests for triploidy.

Screening options >>

Panorama offers patients a personalized risk score, which indicates whether your baby is at high or low risk for genetic disease. Your report may state the following:

PERSONALIZEDRESULTS



LOW RISK

A low risk result indicates that it is very unlikely that your baby is affected by one of the conditions on the Panorama panel.




HIGH RISK

A high risk result does not mean the baby has a chromosomal abnormality; rather, it indicates a very high probability that your baby may have that condition. Your healthcare provider may recommend that you speak with a genetic counselor and/ or maternal fetal medicine specialist. You may be offered invasive diagnostic testing such as amniocentesis or CVS. No irreversible pregnancy decisions should ever be made based on a Panorama result alone.




NO RESULT

In a small percentage of cases, Panorama may not be able to obtain sufficient information from your blood sample to determine an accurate result.

If this occurs, a second blood sample may be requested.


The Panorama process



Physician orders Panorama



Blood sample collected



Sample shipped to
the lab and analyzed



Result sent to physician
in about 10-15 working days


Copyright by AMS 2018. All rights reserved.